CyBio and LiCONiC Instruments Announce a Distribution Partnership
CyBio AG enhances its solutions in robotics integration and liquid handling devices with the incubators of LiCONiC Instruments AG. CyBio France S.A.R.L., the sales subsidiary of CyBio AG, signed a distribution agreement with LiCONiC Instruments AG, Mauren, Liechtenstein. CyBio France obtained the exclusive right to market LiCONiCs product portfolio in France, as well as provide service for the installed instruments base.
LiCONiC is the pioneer in the field of precision robotic incubators and manufacturer of precision robotic incubators and climate controlled robotic storages. The instruments are installed worldwide at leading pharmaceutical and biotechnological companies to facilitate high throughput screening of novel drugs.
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents

The dark matter of the brain - Omnipresent and yet hardly explored: Electrical synapses
New biomarker links cancer progression to genome instability - High level of specific protein in tumors indicates prognosis
KUROS announces allowance of European Patent for synthetic biomaterials
Agilent Technologies and Agendia Sign Agreement on Molecular Cancer Diagnostics
Category:Lyases

Technetics - Freiburg im Breisgau, Germany
Biochrom appoints Sam Luke as the new Group Managing Director

Phase 1 BAFF CAR T clinical trial for patients with relapsed and refractory multiple myeloma underway at UH Seidman Cancer Center - Study is being done through an agreement between UH and start-up Luminary Therapeutics
Category:Sexual_conflict

The role of the tunnel
Proteome atlas for the tuberculosis pathogen
